GeneAb™ BG8, LewisY [IHC517] on Lung Cancer
BG8 Lewisy, also known as Lewisy Blood Antigen or simply BG8, is a blood group antigen that has been identified in many studies as a potential marker for differentiation between pulmonary adenocarcinoma (PACA) and epithelioid mesothelioma (EM). It has been reported that sensitivity of non-mesothelial antigens for adenocarcinoma is organ-dependent. When attempting to differentiate epithelioid mesothelioma from adenocarcinoma, BG8 Lewisy performed at a sensitivity of 98% in the breast cancer group, and 100% in the lung cancer group.
                     CLONE:
                     IHC517
                     ISOTYPE:
                     IgG1, kappa
                     HOST SPECIES:
                     Mouse
                     CLONALITY:
                     Monoclonal
                     POSITIVE CONTROL:
                     Lung Adenocarcinoma
                     DILUTION RANGE:
                     
                     INTENDED USE/REG. STATUS:
                      IVD
                      
                  
					